Total Payments
$8,272
2024 Payments
$210.34
Companies
8
Transactions
46
Medicare Patients
845
Medicare Billing
$99,503
Payment Breakdown by Category
Consulting$4,170 (50.4%)
Food & Beverage$2,123 (25.7%)
Travel$1,975 (23.9%)
Education$3.74 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,170 | 4 | 50.4% |
| Food and Beverage | $2,123 | 29 | 25.7% |
| Travel and Lodging | $1,975 | 12 | 23.9% |
| Education | $3.74 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $4,533 | 19 | $0 (2018) |
| Abbott Laboratories | $1,635 | 18 | $0 (2018) |
| Gilead Sciences Inc | $1,520 | 2 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 1 | $0 (2024) |
| ABIOMED | $160.54 | 2 | $0 (2022) |
| United Therapeutics Corporation | $122.77 | 1 | $0 (2022) |
| PFIZER INC. | $89.64 | 1 | $0 (2019) |
| CVRx, Inc. | $10.34 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $210.34 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($200.00) |
| 2022 | $283.31 | 3 | ABIOMED ($160.54) |
| 2019 | $89.64 | 1 | PFIZER INC. ($89.64) |
| 2018 | $4,913 | 25 | Actelion Pharmaceuticals US, Inc. ($3,520) |
| 2017 | $2,776 | 14 | Gilead Sciences Inc ($1,520) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 02/08/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $3.81 | General |
| Category: Heart Failure and Hypertension | ||||||
| 01/10/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $6.53 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/30/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $84.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $76.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/28/2022 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $122.77 | General |
| 06/25/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $89.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $461.35 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $141.39 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $109.97 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $62.84 | General |
| 12/01/2018 | Actelion Pharmaceuticals US, Inc. | — | Travel and Lodging | Cash or cash equivalent | $42.83 | General |
| 11/30/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $50.61 | General |
| 11/30/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $39.37 | General |
| 11/30/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $22.50 | General |
| 11/26/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $165.07 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/11/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $62.01 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/11/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Travel and Lodging | In-kind items and services | $14.36 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/11/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Travel and Lodging | Cash or cash equivalent | $9.62 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/11/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Travel and Lodging | In-kind items and services | $7.99 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/11/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/10/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Travel and Lodging | In-kind items and services | $624.33 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/10/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Travel and Lodging | Cash or cash equivalent | $169.12 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/10/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Travel and Lodging | In-kind items and services | $125.35 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 09/10/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $117.13 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 213 | 454 | $137,178 | $28,859 |
| 2022 | 7 | 234 | 430 | $120,164 | $26,838 |
| 2021 | 6 | 218 | 433 | $97,901 | $26,846 |
| 2020 | 6 | 180 | 312 | $66,274 | $16,959 |
Total Patients
845
Total Services
1,629
Medicare Billing
$99,503
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 246 | $63,714 | $14,719 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 92 | 123 | $44,280 | $8,255 | 18.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 33 | $16,236 | $3,361 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 36 | 39 | $9,555 | $1,705 | 17.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 13 | $3,393 | $819.39 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 97 | 142 | $41,758 | $10,199 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 171 | $43,265 | $9,028 | 20.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 37 | $13,801 | $2,949 | 21.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 21 | $10,806 | $2,221 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 34 | $7,022 | $1,675 | 23.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $2,637 | $618.25 | 23.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 14 | 14 | $875.00 | $148.69 | 17.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 194 | $47,142 | $11,066 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 89 | 138 | $28,842 | $10,206 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 50 | 56 | $7,616 | $2,483 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 21 | $10,773 | $2,266 | 21.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 12 | $2,664 | $685.56 | 25.7% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 12 | 12 | $864.00 | $140.04 | 16.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 78 | 115 | $24,035 | $6,838 | 28.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 116 | $28,188 | $6,750 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 21 | $7,371 | $1,759 | 23.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 19 | 20 | $2,264 | $732.38 | 32.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 24 | $3,264 | $710.80 | 21.8% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 16 | 16 | $1,152 | $169.06 | 14.7% |
About Dr. David Silber, MD
Dr. David Silber, MD is a Cardiovascular Disease healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336197268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Silber, MD has received a total of $8,272 in payments from pharmaceutical and medical device companies, with $210.34 received in 2024. These payments were reported across 46 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($4,170).
As a Medicare-enrolled provider, Silber has provided services to 845 Medicare beneficiaries, totaling 1,629 services with total Medicare billing of $99,503. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Hershey, PA
- Active Since 05/04/2006
- Last Updated 11/09/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336197268
Products in Payments
- Letairis (Drug) $1,520
- HeartMate 3 Left Ventricular Assist Device (Device) $810.19
- HeartMate 3 Left Ventricular Dev (Device) $582.81
- Circulatory Support (Device) $242.44
- Adempas (Drug) $200.00
- Impella (Device) $160.54
- OPSUMIT MACITENTAN (Drug) $147.73
- VYNDAQEL (Drug) $89.64
- Barostim Neo System (Device) $10.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Hershey
Gerald Naccarelli, Md, MD
Cardiovascular Disease — Payments: $455,121
Cardiovascular Disease $455,121
Mario Gonzalez, Md, MD
Cardiovascular Disease — Payments: $244,348
Cardiovascular Disease $244,348
John Boehmer, Md, MD
Cardiovascular Disease — Payments: $234,176
Cardiovascular Disease $234,176
Dr. Alon Yarkoni, M.d, M.D
Cardiovascular Disease — Payments: $100,425
Cardiovascular Disease $100,425
Michael Pfeiffer, M.d, M.D
Cardiovascular Disease — Payments: $85,074
Cardiovascular Disease $85,074
Howard Eisen, Md, MD
Cardiovascular Disease — Payments: $18,635
Cardiovascular Disease $18,635